A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes.
about
Review: Gout: A Roadmap to Approaches for Improving Global OutcomesRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisSerum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studiesImpact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment optionsTrajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study.Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.Metabolic Risk Factors of Type 2 Diabetes Mellitus and Correlated Glycemic Control/Complications: A Cross-Sectional Study between Rural and Urban Uygur Residents in Xinjiang Uygur Autonomous Region.Insight into rheumatological cause and effect through the use of Mendelian randomization.Mendelian randomization analysis indicates serum urate has a causal effect on renal function in Chinese women.Physiological functions and pathogenic potential of uric acid: A review.Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study.Opposing effects of sodium intake on uric acid and blood pressure and their causal implication.DNA hypomethylation of a transcription factor binding site within the promoter of a gout risk gene NRBP1 upregulates its expression by inhibition of TFAP2A bindingSerum uric acid levels are associated with homeostasis model assessment in obese nondiabetic patients: HOMA and uric acid.Uric acid and cardiovascular risk: What genes can say.Cardiac and renal protective effects of urate-lowering therapy.MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank.Causal or Noncausal Relationship of Uric Acid With Diabetes.Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses.Physiology of Hyperuricemia and Urate-Lowering Treatments.Prioritising Risk Factors for Type 2 Diabetes: Causal Inference through Genetic Approaches.Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver
P2860
Q28076018-43B5CC95-DCE2-4132-AA62-9E6006066028Q28354735-2A0A9122-DE32-4864-A7F2-A502EE402CEAQ33770852-0B9F0E55-7DF1-4952-B083-223849FBF06CQ33864537-893582D8-FB1B-4DEA-BCA7-1F18C1918EB1Q33920095-772C6B43-4C89-4D97-9BDB-436337FCBB2BQ34682703-0C752836-64FB-4AC7-B987-4A6B41D15265Q36131148-2EC19C56-7DC6-4F13-BCCB-BAB12D0081D4Q38895577-2417C06A-064B-4B71-B428-C4F575DD7585Q40063835-549F6D1F-F521-4352-8E57-F88035D348E0Q40117885-8C0AAA8A-5311-4964-9033-3A145A9E4587Q40238562-74EE11A9-BAD8-4725-AAE2-897D09DB78B1Q40431657-DD7D0957-772B-4883-8404-A595EA0CC895Q41712674-CFDAF0B9-72FF-48B6-8522-B4CF6000F461Q42376724-17E83E93-EB9F-4E7F-8C3E-F1EA6157D9EEQ48102504-02D9DB4A-6F34-4B8C-A2C1-19925FCBBAE6Q49616077-856C6303-BA2F-49FE-971B-80F4A3B3D28FQ50044432-1E603D3D-E11A-4800-9040-EEAB02D94222Q55027950-1D032E22-4EE1-4A10-AF6B-96190F591AC4Q55051421-BE70F7DB-BDE8-46E8-9C37-FC0FEFE70045Q55163806-081226CE-DE52-4FA6-BFCE-35BFE6BD6573Q55260964-0EE95C77-329F-4405-ACFD-BD39A83091A2Q58799660-7F976A54-BB82-42A2-BAA2-74C1DDA930BA
P2860
A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes.
@en
type
label
A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes.
@en
prefLabel
A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes.
@en
P2093
P50
P356
P1433
P1476
A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes
@en
P2093
Annemieke M W Spijkerman
Aurelio Barricarte
Beverley Balkau
Daphne L van der A
Diana Gavrila
Françoise Clavel-Chapelon
Heiner Boeing
InterAct Consortium
Ivonne Sluijs
J Ramón Quirós
P304
P356
10.2337/DB14-0742
P407
P50
P577
2015-04-27T00:00:00Z